304 related articles for article (PubMed ID: 16407849)
1. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
Chen J; Kremer CS; Bender TP
Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
3. A novel system to identify Myb target promoters in friend murine erythroleukemia cells.
Chen J; Bender TP
Blood Cells Mol Dis; 2001; 27(2):429-36. PubMed ID: 11500057
[TBL] [Abstract][Full Text] [Related]
4. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
Chen J; Kremer CS; Bender TP
Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
[TBL] [Abstract][Full Text] [Related]
5. cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation.
Suhasini M; Reddy CD; Reddy EP; DiDonato JA; Pilz RB
Oncogene; 1997 Oct; 15(15):1859-70. PubMed ID: 9362453
[TBL] [Abstract][Full Text] [Related]
6. GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter.
Bartůnek P; Králová J; Blendinger G; Dvorák M; Zenke M
Oncogene; 2003 Apr; 22(13):1927-35. PubMed ID: 12673198
[TBL] [Abstract][Full Text] [Related]
7. [Expression of protooncogenes c-myb and c-myc during the hexamethylene bisacetamide (HMBA)-induced commitment to terminal differentiation of murine erythroleukemia cells].
Chen ZX
Zhonghua Zhong Liu Za Zhi; 1991 Jul; 13(4):261-4. PubMed ID: 1806345
[TBL] [Abstract][Full Text] [Related]
8. Hexamethylene bisacetamide-induced differentiation of transformed cells: molecular and cellular effects and therapeutic application.
Marks PA; Rifkind RA
Int J Cell Cloning; 1988 Jul; 6(4):230-40. PubMed ID: 3047266
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the transcriptional factor GATA-1 in regulation of expression of coproporphyrinogen oxidase in mouse erythroleukemia cells.
Tanabe A; Furukawa T; Ogawa Y; Yamamoto M; Hayashi N; Tokunaga R; Taketani S
Biochem Biophys Res Commun; 1997 Apr; 233(3):729-36. PubMed ID: 9168923
[TBL] [Abstract][Full Text] [Related]
10. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
11. Induced differentiation of murine erythroleukemia cells (MELC) by polar compounds: marked increased sensitivity of vincristine resistant MELC.
Marks PA; Michaeli J; Jackson J; Richon VM; Rifkind RA
Prog Clin Biol Res; 1989; 316B():171-81. PubMed ID: 2616574
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional elongation of c-myb is regulated by NF-kappaB (p50/RelB).
Suhasini M; Pilz RB
Oncogene; 1999 Dec; 18(51):7360-9. PubMed ID: 10602492
[TBL] [Abstract][Full Text] [Related]
13. Deregulated c-Myb expression in murine myeloid leukemias prevents the up-regulation of p15(INK4b) normally associated with differentiation.
Schmidt M; Koller R; Haviernik P; Bies J; Maciag K; Wolff L
Oncogene; 2001 Sep; 20(43):6205-14. PubMed ID: 11593429
[TBL] [Abstract][Full Text] [Related]
14. c-myb effects on kinetic events during MEL cell differentiation.
Danish R; el-Awar O; Weber BL; Langmore J; Turka LA; Ryan JJ; Clarke MF
Oncogene; 1992 May; 7(5):901-7. PubMed ID: 1533276
[TBL] [Abstract][Full Text] [Related]
15. Chromatin immunoselection defines a TAL-1 target gene.
Cohen-Kaminsky S; Maouche-Chrétien L; Vitelli L; Vinit MA; Blanchard I; Yamamoto M; Peschle C; Roméo PH
EMBO J; 1998 Sep; 17(17):5151-60. PubMed ID: 9724651
[TBL] [Abstract][Full Text] [Related]
16. Changes in gene expression during hexamethylene bisacetamide induced erythroleukemia differentiation.
Marks PA; Ramsay R; Sheffery M; Rifkind RA
Prog Clin Biol Res; 1987; 251():253-68. PubMed ID: 3481077
[TBL] [Abstract][Full Text] [Related]
17. Conditional inhibition of erythroid differentiation by c-Myb/oestrogen receptor fusion proteins.
Lyon JJ; Watson RJ
Differentiation; 1995 Oct; 59(3):171-8. PubMed ID: 7589901
[TBL] [Abstract][Full Text] [Related]
18. Myb proteins regulate the expression of diverse target genes.
Lang G; White JR; Argent-Katwala MJ; Allinson CG; Weston K
Oncogene; 2005 Feb; 24(8):1375-84. PubMed ID: 15608679
[TBL] [Abstract][Full Text] [Related]
19. DNA binding-independent transcriptional activation of the vascular endothelial growth factor gene (VEGF) by the Myb oncoprotein.
Lutwyche JK; Keough RA; Hunter J; Coles LS; Gonda TJ
Biochem Biophys Res Commun; 2006 Jun; 344(4):1300-7. PubMed ID: 16650815
[TBL] [Abstract][Full Text] [Related]
20. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
